Percentage of Patients to Benefit From Immune Checkpoint Inhibitors Still Limited

The percentage of patients with cancer eligible to receive immune checkpoint inhibitors has increased in recent years, but how many patients are actually responding?

Source: CancerNetwork - May 7, 2019 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news